Borregaard ASA (BRG) Fair Value & Analysis
Basic Materials · NO · Market cap 14.2B NOK
Fair value as of: Jun 24, 2026
From 24 valuation models · updated 5 days ago
Share price +4.2% over the past month.
Price vs Fair Value (12 months)
12‑month range kr 134.12 – kr 199.37 · fair‑value band kr 54.01 – kr 132.22 · the kr 144.20 price screens above the kr 95.67 fair value. As of Jun 24, 2026.
✦ Which stocks are undervalued right now? Check free Discover now →Analysis
Borregaard ASA (BRG) currently trades at kr 144.20, while our model-based Fair Value estimate is kr 95.67 — implying the stock looks roughly 33.7% overvalued today. We read business quality at 95/100 (high quality), in the Basic Materials sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: high).
Over the trailing twelve months, Borregaard ASA generated revenue of 7.7B NOK at a net margin of 7.2%. Revenue declined 1.5% year over year. It earns a return on equity of 8.8%. Net debt stands at 2.1B NOK. Fundamentals as of Jun 24, 2026
Key figures & financial health
More key figures
Figures from reported company fundamentals (EODHD) · as of Jun 24, 2026. TTM = trailing twelve months.
About the company
Borregaard ASA engages in the development, production, and marketing of specialized biochemicals and biomaterials in Norway, rest of Europe, Asia, the United States, and internationally. It operates in three segments: BioSolutions, BioMaterials, and Fine Chemicals. The BioSolutions segment develops, produces, and sells biopolymers and biovanillin derived from lignin for agrochemicals, batteries, industrial binders, and construction, as well as to flavor and fragrance companies, and food and beverage industry. Its BioMaterials segment develops, produces, and sells speciality cellulose used as a raw material in the production of cellulose ethers, cellulose acetate, and other specialty products, as well as cellulose fibrils for industrial applications. The Fine Chemicals segment supplies fine chemical intermediates for contrast agents and advanced bioethanol. The company was incorporated in 2012 and is headquartered in Sarpsborg, Norway.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
Borregaard ASA reported revenue of kr 7.6B in FY2025 versus kr 5.8B in FY2021, a compound +6.9%/yr. Reported net income was kr 620M in FY2025, compounding −2.7%/yr from FY2021.
Open the full interactive analysis →
Similar stocks
6 more Specialty Chemicals stocks, each showing price versus our Fair Value estimate (as of Jun 24, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Linde plc LIN | $509.16 | $159.69 | -69% |
| L'Air Liquide S.A AIQUY | $38.20 | $13.08 | -66% |
| Air Products and Chemicals, Inc A1PD34 | R$364.32 | R$50.60 | -86% |
| Intercontinental Exchange, Inc I1CE34 | R$334.47 | R$67.12 | -80% |
| Wanhua Chemical Group 600309 | ¥72.46 | ¥51.34 | -29% |
| Asian Paints Limited ASIANPAINT | ₹2,674 | ₹739.38 | -72% |
Explore undervalued stocks
More undervalued Basic Materials stocks →
Frequently asked questions
Is Borregaard ASA (BRG) undervalued?
What is the fair value of BRG?
What is the quality score of BRG?
What is the revenue of Borregaard ASA (BRG)?
What is the net profit margin of BRG?
Does Borregaard ASA pay a dividend?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.